| Previous Close | 76.55 |
|---|---|
| Volume | 577,912 |
| Day's Range | 76.21 - 77.60 |
| 52-Week Range | 57.14 - 84.00 |
| Year-to-Date Return | 9.56% |
|---|---|
| 1-Year Return | 12.69% |
| 3-Year Annualized Return | -1.01% |
| 5-Year Annualized Return | 1.82% |
| Expense Ratio | 0.48 |
|---|---|
| Net Assets | $ 1,353 mil |
| Alpha | 0.18 |
| R-Squared | 0.43 |
| Dividend (Yield) | $0.00 (0.00%) |
| Avg. Market Cap | $ 17,981 mil |
| Beta | 0.66 |
| Price/Earnings | 33.52 |
| Ex-Dividend Date | NA |
| Turnover | 11.00 |
| Standard Deviation | 5.77 |
| Price/Book | 5.66 |
| Management Company | Barclays Global Fund Advisors |
| Administrator | Barclays Global Fund Advisors |
| Company of Name | % of Total | # of Shares Held |
|---|---|---|
| 1. Amgen | 11.47% | 2,978,250 |
| 2. Gilead Sciences Inc | 8.55% | 2,943,083 |
| 3. Teva Pharmaceutical Industries Ltd | 7.58% | 2,284,280 |
| 4. Celgene Corp | 6.33% | 1,882,797 |
| 5. Vertex Pharma | 3.75% | 1,553,634 |
| 6. Biogen Idec Inc | 3.36% | 1,039,853 |
| 7. Genzyme Corp | 3.16% | 880,711 |
| 8. Alexion Pharm | 2.51% | 861,846 |
| 9. Illumina Inc | 2.39% | 1,049,283 |
| 10. Life Technologies Corp | 2.04% | 709,112 |
| % of Total Holdings | 51.14% |